Behavioural effect of Pavetta crassipes extract on rodents

Pharmacology Biochemistry and Behavior

Volumn 77, Issue 4, 2004, Pages 751-759

  Amos, Samson ^a,b,e   Akah, Peter A ^c   Enwerem, Nkechi ^d   Chindo, Ben A ^a   Hussaini, Isa M ^b   Wambebe, Charles ^a   Gamaniel, Karniyus ^a  

^a NATIONAL INSTITUTE FOR PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (Nigeria)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c UNIVERSITY OF NIGERIA   (Nigeria)

^d HOWARD UNIVERSITY   (United States)

^e UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Behaviour; Central nervous system; Dopaminergic pathways; Pavetta crassipes; Sleep

Indexed keywords

AMPHETAMINE; APOMORPHINE; HALOPERIDOL; PAVETTA CRASSIPES EXTRACT; PHENOBARBITAL; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALEPSY; CLIMBING; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EXPLORATORY BEHAVIOR; FEMALE; HYPERACTIVITY; HYPNOSIS; MALE; MEDICINAL PLANT; MOTOR ACTIVITY; MOTOR COORDINATION; MOUSE; NONHUMAN; PAVETTA CRASSIPES; PRIORITY JOURNAL; SLEEP TIME; STEREOTYPY;

ANIMALS; APOMORPHINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; MICE; MOTOR ACTIVITY; PLANT EXTRACTS; PLANT LEAVES; RATS; RATS, WISTAR; RUBIACEAE; STEREOTYPED BEHAVIOR;

PAVETTA; RODENTIA;

EID: 1942487831     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2004.01.020     Document Type: Article

References (43)

1. Amos S., Okwuasaba F.K., Gamaniel K., Akah P., Wambebe C. Inhibitory effects of the aqueous extract of Pavetta crassipes leaves on gastrointestinal and uterine smooth muscle preparations isolated from rabbits, guinea pigs and rats. J. Ethnopharmacol. 61:1998;209-213.
2. Amos S., Okwuasaba F.K., Gamaniel K., Akah P., Wambebe C. Anti inflammatory and muscle relaxant effects of the aqueous extract of Pavetta crassipes leaves. Fitoterapia. 69:1998;425-429.
3. Amos S., Kolawole E., Akah P., Wambebe C., Gamaniel K. Behavioural effects of the aqueous extract of Guiera senegalensis in mice and rats. Phytomedicine. 8:2001;356-361.
4. Amos S., Adzu B., Binda L., Wambebe C., Gamaniel K. Neuropharmacological effects of the aqueous extract of Spharanthus senegalensis in mice. J. Ethnopharmacol. 78:2001;33-37.
5. Anca J.M., Lamela M., Calleja J.M. Activity on the central nervous system of Himanthalia elongata. Planta Med. 59:1993;218-220.
6. Baldessarini R.J. Drugs and the treatment of psychiatric disorders. Alfred G.G., Theodore W., Alan S.N., Palmer T. Pharmacological basis of therapeutics. 8th ed. 1990;383-435 Pergamon, New York.
7. Balsara J.J., Jadhav J.H., Chandokar A.G. Effect of drugs influencing central serotonergic mechanism on haloperidol-induced catalepsy. Psychopharmacology. 62:1979;67-69.
8. Balsara J.J., Nandal N.V., Burte N.P., Jadhav J.H., Chandokar A.G. Effects of naloxone on methamphetamine and apomorphine stereotypy and haloperidol catalepsy in rats. Psychopharmacology (Berl.). 82:1984;237-240.
9. Capaso A., De feo V., De Simone F., Sorrentino L. Pharmacological effects of the aqueous extract from Valeriana adscenden. Phytother. Res. 10:1996;309-312.
10. Carpendo R., Chiarugi A., Russi P., Lombardi G., Carla V., Pelliciari R.et al. Inhibitors of kynerenine hydroxylase and kynurenase increase cerebral formation of kynurenate and have sedative and anti-convulsant activities. Neuroscience. 61:1994;237-243.
11. Chhabra S.C., Mahunnah R.L.A., Mshin E.N. Plants used in Eastern Tanzania V. J. Ethnopharmacol. 33(1961):1991;143-157.
12. Costall B., Naylor R.J., Nohria V. Climbing behaviour induced by apomorphine in mice. A potent model for the detection of neuroleptic activity. Eur. J. Pharmacol. 50:1978;39-50.
13. Ellinwood E.H., Sudilosky B., Nelson L.M. Evolving behaviour in the clinical and experimental amphetamine (model) psychosis. Am. J. Psychiat. 730:1973;1088-1090.
14. Evans W.C. Trease and Evans pharmacognosy. 14th ed. 1996;780 Saunders, London.
15. Farnsworth N.R. The development of pharmacological and chemical research for application of traditional medicine in developing countries. J. Ethnopharmacol. 2:1980;173-181.
16. File S.E. Effect of chlorpromazone on exploration and habitation in the rat. Br. J. Pharmacol. 49:1973;303-310.
17. File S., Pellow S. The effect of triazolobenzodiazepines in two animal tests of anxiety and on the hole board. Br. J. Pharmacol. 86:1985;729-735.
18. File S., Wardill A.G. Validity of head-dipping as a measure of explorating a modified hole-board. Psychopharmacology. 44:1975;53-59.
19. Fujimori H. Potentiation of barbital hypnosis as an evaluation method for central nervous system depressant. Psychopharmacology. 7:1965;374-377.
20. Fujimori H., Cobb D. Central nervous system depressant activity of MA 1337, 3-[3,4-m-chlorophenyl-1-piperazyl prophyl]-1-2-4 (1H, 3H) quinozolinedione hydrochloride. J. Pharmacol. Exp. Ther. 148:1965;151-157.
21. Gada V.P., Nandal N.V., Balsara J.J., Chandokar A.G. Effect of alpha-methyl-ptyrosine on neuroleptic induced catalepsy in rats. Indian J. Physiol. Pharmacol. 27:1983;241-244.
22. Gbeassor M., Kosson Y., Amegbol K., De souza C., Koumaglo K., Denke A. Antimalarial effects of eight African medicinal plants. J. Ethnopharmacol. 25:1989;115-118.
23. Hoffman B.B., Lefkowitz R.J. Catecholamines, symphathomimetic drugs, and adrenergic receptor antagonists. Hardman J.G., Limbird L.E., Molinoff P.M., Ruddon R.W., Gilman A.G. Goodman and Gilman's Pharmacological Basis of Therapeutics. 9th ed. 1996;199-248 McGraw-Hill, New York.
24. Irvine F.R. Woody plants of Ghana. 1961;698 Oxford Univ. Press, London.
25. Irwin S. Comprehensive observational assessment: 1a. A systematic quantitative procedure for assessing the behavioural and physiologic state of the mouse. Psychopharmacology. 13:1968;222-257.
26. Kalkman H.O., Neumann V., Nozulak J., Triklebank M.D. Cataleptogenic effect of subtype selective 5-HT receptor antagonists in the rat. Eur. J. Pharmacol. 343:1998;201-207.
27. Kaul P.N., Kulkarni S.K. New drug metabolism inhibitor of marine origin. J. Pharm. Sci. 67:1978;1293-1296.
28. Khisti R.T., Mandane S.N., Chopde C.T. Haloperidol-induced catalepsy: a model for screening antidepressants effective in the treatment of depression with Parkinson's disease. Indian J. Exp. Biol. 35:1997;1297-1301.
29. Koch-Weser J., Greenblatt D.J. The archaic barbiturate hyponotics. N. Engl. J. Med. 291:1974;790-791.
30. Mansur J., Martz R.M.W., Carlini E.A. Effects of acute and chronic administration of Cannabis sativa and (-) 9-trans tetrahedron cannabinol on the behaviour of rats in an open field arena. Psychopharmacology. 19:1971;338-397.
31. Moore N.A., Axton M.S. Production of climbing behaviour in mice requires both D1and D2 receptors activation. Psychopharmacology. 94:1988;263-266.
32. Muley M.P., Balsara J.J., Jadhav J.H., Chandokar A.G. Involvement of histaminergic mechanisms in the cataleptogenic effect of morphine in mice. J. Pharm. Pharmacol. 34:1982;34-37.
33. N'Gouemo P., Nquemby-Bina C., Baldy-Monlinier M. Some neuropharmacological effects of an ethanol extract of Maprounea africana in rodents. J. Ethnopharmacol. 43:1994;161-166.
34. Ozturk Y., Aydine S., Ben R., Baser K.H.C., Berberoglu H. Behavioural effects of Hypericum perforatum L and Hypericum calycinum L. extracts on the central nervous systems in mice. Phytomedicine. 3:1996;139-146.
35. Perez R.M.G., Perez J.A.L., Garcia L.M.D., Sossa H.M. Neuropharmacological activity of Solanum nigrum fruit. J. Ethnopharmacol. 62:1998;43-48.
36. Protais P., Costertin J., Schwartz J.C. Climbing behaviour induced by apomorphine in mice. A simple test for the study of dopamine receptors in the striatum. Psychopharmacology. 50:1976;1-6.
37. Randrup A., Munkvad I. Stereotyped activities produced by amphetamine in several animal species and man. Psychopharmacologia. 11:1967;300-310.
38. Reavill C., Kettle A., Holland V., Riley G., Blackburn T.P. Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist. Br. J. Pharmacol. 126:1999;572-574.
39. Soulimani R., Younos C., Jamouni-Idrissi S., Bousa D., Khalonki F., Haila A. Behavioural and pharmacotoxicological study of Papaver rhoeas L. in mice. J. Ethnopharmacol. 74:2001;265-274.
40. Takeda H., Tsuji M., Matsumiya T. Changes in head dipping behaviour in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice. Eur. J. Pharmacol. 350:1998;21-29.
41. Wambebe C. Influence of some agents that affect 5-HT metabolism and receptors and nitrazepam-induced sleep in mice. Br. J. Pharmacol. 84:1985;185-191.
42. Wolfman C., Viola H., Paladini A.C., Daja's D., Medina J.N. Possible anxiolytic effects of chrysin, a central benzodiazapine receptor ligand isolated from Passiflora coerulea. Pharmacol. Biochem. Behav. 47:1994;1-4.
43. World Health Organization (WHO) Resolution on drug policies and management of medicinal plants, WHO document WHA. 1978;31-33.